Pope JE - Search Results

1

Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.

Harrold LR, Bingham CO, Pope JE, O'Brien J, Moore PC, Roberts-Toler C, Yu M, Sweet LL, Shelbaya A, Masri KR. Harrold LR, et al. Among authors: pope je. Clin Rheumatol. 2024 Dec 20. doi: 10.1007/s10067-024-07245-3. Online ahead of print. Clin Rheumatol. 2024. PMID: 39707042

2

Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.

Barra L, Pope JE, Payne M. Barra L, et al. Among authors: pope je. J Rheumatol. 2009 Jul;36(7):1421-8. doi: 10.3899/jrheum.081122. Epub 2009 Jun 1. J Rheumatol. 2009. PMID: 19487267

3

Canadian variation by province in rheumatoid arthritis initiating anti-tumor necrosis factor therapy: results from the optimization of adalimumab trial.

Pease C, Pope JE, Thorne C, Haraoui BP, Truong D, Bombardier C, Widdifield J, Psaradellis E, Sampalis JS, Bonner A. Pease C, et al. Among authors: pope je. J Rheumatol. 2010 Dec;37(12):2469-74. doi: 10.3899/jrheum.091447. Epub 2010 Sep 15. J Rheumatol. 2010. PMID: 20843910

4

The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.

Pope JE, Khanna D, Norrie D, Ouimet JM. Pope JE, et al. J Rheumatol. 2009 Feb;36(2):254-9. doi: 10.3899/jrheum.080479. J Rheumatol. 2009. PMID: 19132791

5

Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.

Yuen SY, Rochwerg B, Ouimet J, Pope JE. Yuen SY, et al. Among authors: pope je. J Rheumatol. 2008 Jun;35(6):1073-8. Epub 2008 Apr 15. J Rheumatol. 2008. PMID: 18412305

6

Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor.

Aberumand B, Barra L, Cao Y, Riche NL, Thompson AE, Rohekar G, Rohekar S, Bonner A, Pope JE. Aberumand B, et al. Among authors: pope je. Open Rheumatol J. 2014 Oct 17;8:73-6. doi: 10.2174/1874312901408010073. eCollection 2014. Open Rheumatol J. 2014. PMID: 25352925 Free PMC article.

7

Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention.

Pope J, Finckh A, Silva-Fernández L, Mandl P, Fan H, Rivas JL, Valderrama M, Montoro M. Pope J, et al. Open Access Rheumatol. 2024 Jun 11;16:115-126. doi: 10.2147/OARRR.S446431. eCollection 2024. Open Access Rheumatol. 2024. PMID: 38883150 Free PMC article.

8

Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.

Barra L, Bykerk V, Pope JE, Haraoui BP, Hitchon CA, Thorne JC, Keystone EC, Boire G; Catch Investigators. Barra L, et al. Among authors: pope je. J Rheumatol. 2013 Aug;40(8):1259-67. doi: 10.3899/jrheum.120736. Epub 2013 Feb 1. J Rheumatol. 2013. PMID: 23378461

9

Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study.

Pyne L, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Keystone EC, Pope JE; CATCH Investigators. Pyne L, et al. Among authors: pope je. J Rheumatol. 2012 Nov;39(11):2081-7. doi: 10.3899/jrheum.120520. Epub 2012 Sep 1. J Rheumatol. 2012. PMID: 22942265

10

Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.

Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. Saketkoo LA, et al. J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. J Rheumatol. 2014. PMID: 24488412 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters